Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Some Immuno-Oncology Drugs Carry Risk of Rare Heart Damage
Some Immuno-Oncology Drugs Carry Risk of Rare Heart Damage
Some Immuno-Oncology Drugs Carry Risk of Rare Heart Damage
Submitted by
admin
on November 7, 2016 - 9:17pm
Source:
Xtalks
News Tags:
immuno-oncology
heart damage
Opdivo
Yervoy
Bristol-Myers Squibb
anti-PD-1 immunotherapy
Headline:
Some Immuno-Oncology Drugs Carry Risk of Rare Heart Damage
Do Not Allow Advertisers to Use My Personal information
